Annual EBITDA
-$250.12M$81.67M-48.48%
Summary
- Current Value
- As of today, SRRK annual EBITDA is -$250.12M, down -48.48% on
- Historical Performance
- SRRK annual EBITDA is down -96.49% over the past 3 years, and down -369.80% over the past 5 years
- All-Time High Comparison
- SRRK annual EBITDA is currently -1499.72% below its historical high of -$15.64M set on
- 3-Year Low Comparison
- SRRK annual EBITDA is at its 3-year low
- Sector Comparison
- SRRK annual EBITDA is higher than 5.42% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | -$250.12M | -48.5% | -96.5% | -369.8% | -1499.7% | |
| Quarterly EBITDA | -$103.13M | -60.3% | -149.2% | -349.1% | -2153.2% | |
| TTM EBITDA | -$360.48M | -57.8% | -206.3% | -411.2% | -7775.9% | |
| Price | $44.23 | +9.3% | +372.5% | -6.3% | – | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $0.00 | 0.0% | -100.0% | -100.0% | -100.0% | |
| Annual EPS | -$2.47 | -24.0% | +31.3% | -33.2% | -284.3% | |
| Annual EBIT | -$252.05M | -47.1% | -94.0% | -362.1% | -1454.9% | |
| Annual Net Income | -$246.29M | -48.6% | -86.9% | -382.9% | -1419.7% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | -$131.38M | N/A | -90.4% |
| 5Y | -$85.39M | N/A | -192.9% |
| All | -$15.64M | -1499.7% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$250.12M | at low | |
| 5Y | -$250.12M | at low | |
| All | -$250.12M | at low |
EBITDA History
| Year | Value | Change |
|---|---|---|
| -$250.12M | -48.5% | |
| -$168.45M | -28.2% | |
| -$131.38M | -3.2% | |
| -$127.29M | -49.1% | |
| -$85.39M | -60.4% |
| Year | Value | Change |
|---|---|---|
| -$53.24M | -6.7% | |
| -$49.89M | -104.8% | |
| -$24.36M | -55.8% | |
| -$15.64M | - |
FAQ
What is the current annual EBITDA of SRRK?
As of today, SRRK annual EBITDA is -$250.12M
What is 1-year change in SRRK annual EBITDA?
SRRK annual EBITDA is down -48.48% year-over-year
What is 3-year change in SRRK annual EBITDA?
SRRK annual EBITDA is down -96.49% over the past 3 years
How far is SRRK annual EBITDA from its all-time high?
SRRK annual EBITDA is currently -1499.72% below its historical high of -$15.64M set on December 31, 2016
How does SRRK annual EBITDA rank versus sector peers?
SRRK annual EBITDA is higher than 5.42% of companies in Healthcare sector
When is SRRK next annual earnings release?
The next annual earnings release for SRRK is on
Quarterly EBITDA
-$103.13M$8.57M+7.67%
Summary
- Current Value
- As of today, SRRK quarterly EBITDA is -$103.13M, up +7.67% on
- Historical Performance
- SRRK quarterly EBITDA is down -60.30% year-over-year, and down -149.23% over the past 3 years
- All-Time High Comparison
- SRRK quarterly EBITDA is currently -2187.14% below its historical high of -$4.51M set on
- 3-Year Low Comparison
- SRRK quarterly EBITDA is +7.67% above its 3-year low of -$111.69M reached on
- Sector Comparison
- SRRK quarterly EBITDA is higher than 2.98% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | -$103.13M | +7.7% | -60.3% | -149.2% | -349.1% | |
| Annual EBITDA | -$250.12M | – | -48.5% | -96.5% | -369.8% | |
| TTM EBITDA | -$360.48M | -12.1% | -57.8% | -206.3% | -411.2% | |
| Price | $44.23 | +12.0% | +9.3% | +372.5% | -6.3% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $0.00 | 0.0% | 0.0% | 0.0% | -100.0% | |
| Quarterly EPS | -$0.90 | +7.9% | -35.3% | -64.7% | -13.6% | |
| Quarterly EBIT | -$103.55M | +7.6% | -59.9% | -136.1% | -338.4% | |
| Quarterly Net Income | -$102.22M | +7.1% | -58.5% | -136.1% | -333.9% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$68.96M | N/A | -49.5% |
| 3Y | -$36.51M | -182.5% | |
| 5Y | -$4.51M | -2187.1% | |
| All | -$4.51M | -2187.1% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$111.69M | +7.7% | |
| 3Y | -$111.69M | +7.7% | |
| 5Y | -$111.69M | +7.7% | |
| All | -$111.69M | +7.7% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of SRRK?
As of today, SRRK quarterly EBITDA is -$103.13M
What is SRRK quarterly EBITDA most recent change?
SRRK quarterly EBITDA was up +7.67% on September 30, 2025
What is 1-year change in SRRK quarterly EBITDA?
SRRK quarterly EBITDA is down -60.30% year-over-year
How far is SRRK quarterly EBITDA from its all-time high?
SRRK quarterly EBITDA is currently -2187.14% below its historical high of -$4.51M set on March 31, 2022
How does SRRK quarterly EBITDA rank versus sector peers?
SRRK quarterly EBITDA is higher than 2.98% of companies in Healthcare sector
When is SRRK next earnings release?
The next earnings release for SRRK is on
TTM EBITDA
-$360.48M$38.79M-12.06%
Summary
- Current Value
- As of today, SRRK TTM EBITDA is -$360.48M, down -12.06% on
- Historical Performance
- SRRK TTM EBITDA is down -57.75% year-over-year, and down -206.33% over the past 3 years
- All-Time High Comparison
- SRRK TTM EBITDA is currently -7775.86% below its historical high of -$4.58M set on
- 3-Year Low Comparison
- SRRK TTM EBITDA is at its 3-year low
- Sector Comparison
- SRRK TTM EBITDA is higher than 2.89% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | -$360.48M | -12.1% | -57.8% | -206.3% | -411.2% | |
| Annual EBITDA | -$250.12M | – | -48.5% | -96.5% | -369.8% | |
| Quarterly EBITDA | -$103.13M | +7.7% | -60.3% | -149.2% | -349.1% | |
| Price | $44.23 | +12.0% | +9.3% | +372.5% | -6.3% | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $0.00 | 0.0% | 0.0% | -100.0% | -100.0% | |
| TTM EPS | -$3.25 | -7.8% | -31.7% | -14.7% | -35.1% | |
| TTM EBIT | -$362.11M | -12.0% | -56.9% | -184.2% | -395.2% | |
| TTM Net Income | -$353.43M | -12.0% | -56.4% | -169.5% | -394.4% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$250.12M | N/A | -44.1% |
| 3Y | -$122.59M | N/A | -194.1% |
| 5Y | -$83.01M | N/A | -334.3% |
| All | -$4.58M | -7775.9% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$360.48M | at low | |
| 3Y | -$360.48M | at low | |
| 5Y | -$360.48M | at low | |
| All | -$360.48M | at low |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of SRRK?
As of today, SRRK TTM EBITDA is -$360.48M
What is SRRK TTM EBITDA most recent change?
SRRK TTM EBITDA was down -12.06% on September 30, 2025
What is 1-year change in SRRK TTM EBITDA?
SRRK TTM EBITDA is down -57.75% year-over-year
How far is SRRK TTM EBITDA from its all-time high?
SRRK TTM EBITDA is currently -7775.86% below its historical high of -$4.58M set on March 31, 2017
How does SRRK TTM EBITDA rank versus sector peers?
SRRK TTM EBITDA is higher than 2.89% of companies in Healthcare sector
When is SRRK next earnings release?
The next earnings release for SRRK is on
EBITDA Formula
EBITDA = + + +
Data Sources & References
- SRRK Official Website www.scholarrock.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1727196/000110465925111935/0001104659-25-111935-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1727196/000155837025001682/0001558370-25-001682-index.htm
- SRRK Profile on Yahoo Finance finance.yahoo.com/quote/SRRK
- SRRK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/srrk